NanoViricides
NNVC
#10481
Rank
C$49.97 M
Marketcap
C$1.96
Share price
-1.01%
Change (1 day)
-7.46%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): C-$0.62

According to NanoViricides's latest financial reports the company's current EPS (TTM) is C-$0.61. In 2025 the company made an earnings per share (EPS) of C-$0.88 an increase over its 2024 EPS that were of C-$0.98.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.62-29.81%
2025C-$0.88-10%
2024C-$0.98-5.41%
2023C-$1.035.71%
2022C-$0.98-13.58%
2021C-$1.13-66.11%
2020C-$3.331.7%
2019C-$3.28-10.98%
2018C-$3.68-22.35%
2017C-$4.74-10.53%
2016C-$5.30375%
2015C-$1.12-85.19%
2014C-$7.5342.11%
2013C-$5.3026.67%
2012C-$4.18-6.25%
2011C-$4.4614.28%
2010C-$3.90100%
2009C-$1.95-0%
2008C-$1.95-33.33%
2007C-$2.93-0%
2006C-$2.934445.07%
2005C-$0.06442

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
C$10.34-1,786.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$4.98-912.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.96-909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.42-983.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
C-$0.75 22.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C-$2.41 293.18%๐Ÿ‡บ๐Ÿ‡ธ USA